LMD LED Medical Diagnostics Inc

LED Medical Diagnostics Inc. ("LED" or the "Company") (TSX
VENTURE:LMD)(OTCQX:LEDIF)(FRANKFURT:LME) announced today that it has appointed
Mr. Lamar Roberts to the role of Vice President of Sales and Marketing.


Mr. Roberts has held Senior Executive positions with 360imaging, Carestream
Dental and PracticeWorks and has developed an industry reputation for guiding
companies from early growth stages to becoming industry leaders. He also has a
strong background in leading commercial efforts in technical, medical, and
geographically dispersed organizations. "I have had the rare pleasure of
witnessing Lamar's leadership capabilities and unwavering focus on growth while
working with him at Carestream LLC. We are excited that Lamar has chosen to
bring his depth of knowledge to our team at LED Medical. The Company is at an
important juncture in its corporate growth and Lamar is exactly the right person
to guide it to international leadership in its market sector," states Dr. David
Gane, President and CEO. 


LED Medical's VELscope(R) is the world's most frequently used technology to
assist clinicians in screening for oral tissue anomalies, including early stage
oral cancer. Despite this accomplishment, the Company believes that this
technology has significantly more clinical and commercial potential.  


"This is an exciting period for LED Medical. We are assembling the very best
team possible - all proven leaders in their fields - to bring their drive,
creative energy and wisdom to evolve LED Medical into the world leader we all
believe it can be, " states Dr. Gane. 


About VELscope(R) Technology

According to the Oral Cancer Foundation, nearly 42,000 Americans will be
diagnosed with oral or pharyngeal cancer this year. However, that is just over 8
percent of the approximately 640,000 people diagnosed annually on a worldwide
basis. LED Medical's product, the VELscope(R) VX Enhanced Oral Assessment
System, is changing the way dental practitioners examine the oral mucosa and
screen for tissue abnormalities. The VELscope(R) Vx allows a wide variety of
oral abnormalities to be detected - often before they're visible to the
unassisted eye.


The VELscope Vx(R) is further intended to be used by surgeons as a tool to
assist in identifying diseased tissue around a clinically apparent lesion and
thus aid in determining the appropriate margin for surgical excision.


About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED
Medical Diagnostics Inc. is a leading developer of LED-based visualization
technologies for the medical industry. The Company is currently listed on the
Toronto Stock Exchange (TSX-V) under the symbol "LMD", the OTCQX under the
symbol "LEDIF", as well as the Frankfurt Stock Exchange under the symbol "LME".
For more information, visit www.ledmd.com.


Through its wholly-owned subsidiary, LED Dental Inc., the company manufactures
the VELscope(R) Vx Enhanced Oral Assessment System, the first system in the
world to apply tissue fluorescence visualization technology to the oral cavity.
VELscope(R) Vx devices are now used to conduct more screenings for oral cancer
and other oral diseases than any other adjunctive device. To date, there have
been more than 12,000 VELscope(R) Vx systems sold globally and they have been
used to perform more than 25 million exams. For more information, call
604.434.4614 or visit www.leddental.com.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
For media or investor relations, please contact:
LED Medical Diagnostics Inc.
Mark Komonoski, Investor Relations
(403) 255-8483 / Toll-Free: (877) 255-8483
Cell: (403) 470-8384
mark.komonoski@ledmd.com / Skype: mkomonoski

LED Medical Diagnostics (TSXV:LMD)
Historical Stock Chart
From May 2024 to Jun 2024

LED Medical Diagnostics (TSXV:LMD)
Historical Stock Chart
From Jun 2023 to Jun 2024